Compare iShares Bitcoin Trust (IBIT) vs McKesson Corporation (MCK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Bitcoin Trust vs McKesson Corporation — how do they compare? iShares Bitcoin Trust trades at $46.92 (market cap $67.31B), while McKesson Corporation trades at $933.14 (market cap $108.46B). The key difference: McKesson Corporation is the larger of the two by market cap, and McKesson Corporation pays a 0.4% dividend while iShares Bitcoin Trust pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares Bitcoin Trust for 40 Days and McKesson Corporation for 74 Days on average.
| IBIT | MCK | |
|---|---|---|
Market Cap | $67.31B | $108.46B |
Volume | 56,154,544 | 712,607 |
Sector | Crypto-linked | Health |
52-Week High | $68.74 | $995.69 |
52-Week Low | $33.29 | $725.17 |
Typical Hold Time | 40 Days | 74 Days |
Enterprise Value | — | $115.00B |
Dividend Yield | — | 0.4% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IBIT trades at $46.76, down 0.95% on the day, with technical indicators showing mixed signals. The overall technical outlook is bearish despite moving averages suggesting some bullish momentum. Recent news highlights significant institutional interest with BlackRock's IBIT recording $196 million in daily inflows (24/7 Wall Street, 2026-10-04). The stock faces pressure from oscillators but maintains key support levels at $44-$46.
The outlook remains cautious with institutional inflows providing support, but technical weakness and lack of fundamental data create uncertainty. Investment opportunities exist if technical support holds, while risks include market volatility and dependency on broader Bitcoin ETF trends. Investors should monitor institutional flow data and technical breakouts for directional cues.
McKesson (MCK) trades at $910.33, down 1.23% over 24 hours, with a bullish technical signal supported by moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $9.93 surpassing the $9.56 estimate. Revenue grew to $359.05 billion in 2025, though net margins remain thin at 1.12%. Recent news highlights a key distribution extension with CVS Health through 2032, reinforcing growth visibility in pharmaceutical distribution.
The outlook remains positive given analyst consensus favoring Buy ratings (80.65%) and a price target of $956.43, implying ~5% upside. Risks include margin pressure from drug pricing dynamics and policy uncertainty, while institutional accumulation and solid cash flow generation support stability. Earnings momentum and strategic partnerships position MCK for sustained growth, though investors should monitor competitive and regulatory headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares Bitcoin Trust
IBIT is a spot Bitcoin ETF that tracks the price of Bitcoin directly. Managed by BlackRock, it offers investors a regulated way to gain exposure to the digital asset within a traditional brokerage account.
Read more on IBIT →About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →
